Authors:
Selby, GB
Ali, LI
Carter, TH
Veseley, S
Roy, V
Citation: Gb. Selby et al., The influence of health insurance on outcomes of related-donor hematopoietic stem cell transplantation for AML and CML, BIOL BLOOD, 7(10), 2001, pp. 576-576
Authors:
Petersdorf, SH
Kopecky, KJ
Head, DR
Boldt, DH
Balcerzak, SP
Wun, T
Roy, V
Veith, RW
Appelbaum, FR
Citation: Sh. Petersdorf et al., Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblasticleukemia: a Southwest Oncology Group Study, LEUKEMIA, 15(2), 2001, pp. 208-216
Citation: V. Roy, Nineteenth-century critical reception of Pierre-Joseph-Olivier Chauveau's Charles Guerin. The emergence of a national literature (Francophone Canada), VOIX IMAGE, 26(2), 2001, pp. 339-358
Authors:
Mirza, J
Mirza, MS
Roy, V
Lemire, C
Saleh, K
Tremblay, S
Citation: J. Mirza et al., Special repairs to the Bersimis-1 generating tunnel walls to increase power production: a case study, CAN J CIV E, 28(3), 2001, pp. 411-418
Citation: V. Roy et al., Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes, BONE MAR TR, 27(6), 2001, pp. 641-646
Authors:
Roy, V
Belzung, C
Delarue, C
Chapillon, P
Citation: V. Roy et al., Environmental enrichment in BALB/c mice - Effects in classical tests of anxiety and exposure to a predatory odor, PHYSL BEHAV, 74(3), 2001, pp. 313-320
Authors:
Flanigan, RC
Salmon, SE
Blumenstein, BA
Bearman, SI
Roy, V
McGrath, PC
Caton, JR
Munshi, N
Crawford, ED
Citation: Rc. Flanigan et al., Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer, N ENG J MED, 345(23), 2001, pp. 1655-1659
Citation: Je. Wither et al., Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB x NZW)F-1 mice, CLIN IMMUNO, 94(1), 2000, pp. 51-63
Authors:
Abang, AM
Takemoto, MH
Pham, T
Mandanas, RA
Roy, V
Selby, GB
Carter, TH
Citation: Am. Abang et al., Efficacy and safety of oral granisetron versus i.v. granisetron in patients undergoing peripheral blood progenitor cell and bone marrow transplantation, ANTI-CANC D, 11(2), 2000, pp. 137-142
Authors:
Fisher, RI
Dana, BW
LeBlanc, M
Kjeldsberg, C
Forman, JD
Unger, JM
Balcerzak, SP
Gaynor, ER
Roy, V
Miller, T
Citation: Ri. Fisher et al., Interferon alfa consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: Results of the Southwest Oncology Group randomized phase III study 8809, J CL ONCOL, 18(10), 2000, pp. 2010-2016
Citation: V. Roy et al., Establishment, growth and survival of natural regeneration after clearcutting and drainage on forested wetlands, FOREST ECOL, 129(1-3), 2000, pp. 253-267
Citation: V. Roy et al., Routine chest radiography for the evaluation of febrile neutropenic patients after autologous stem cell transplantation, AM J HEMAT, 64(3), 2000, pp. 170-174
Citation: V. Roy et De. Hammerschmidt, Disseminated histoplasmosis following prolonged low-dose methotrexate therapy, AM J HEMAT, 63(1), 2000, pp. 59-60
Citation: V. Roy et al., Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease, J INFECTION, 41(3), 2000, pp. 273-275
Citation: V. Roy et Cm. Verfaillie, Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: Implications for anatomical localization and developmental stage specific regulation of hematopoiesis, EXP HEMATOL, 27(2), 1999, pp. 302-312
Authors:
Roy, V
Bernier, PY
Plamondon, AP
Ruel, JC
Citation: V. Roy et al., Effect of drainage and microtopography in forested wetlands on the microenvironment and growth of planted black spruce seedlings, CAN J FORES, 29(5), 1999, pp. 563-574
Citation: Mj. Rosenberg et al., Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: A randomized trial of 20 mu g and 35 mu g estrogen preparations, CONTRACEPT, 60(6), 1999, pp. 321-329